The orphan nuclear receptor, estrogen receptor-related receptor a (ERRa) is expressed in osteoblasts and osteoclasts (OCs) and has been proposed to be a modulator of estrogen signaling. To determine the role of ERRa in OC biology, we knocked down ERRa activity by transient transfection of an siRNA directed against ERRa in the RAW264.7 monocytemacrophage cell line that differentiates into OCs in the presence of receptor activator of nuclear factor kB-ligands and macrophage colony-stimulating factor. In parallel, stable RAW cell lines expressing a dominant-negative form of ERRa and green fluorescent protein (RAW-GFP-ERRaDAF2) were used. Expression of OC markers was assessed by real-time PCR, and adhesion and transmigration tests were performed. Actin cytoskeletal organization was visualized using confocal microscopy. We found that RAW264.7 cells expressing siRNA directed against ERRa and RAW-GFPERRaDAF2 OCs displayed abnormal spreading, and decreased osteopontin and b3 integrin subunit expression compared with the corresponding control cells. Decreased adhesion and the absence of podosome belts concomitant with abnormal localization of c-src were also observed in RAW-GFP-ERRaDAF2-derived OCs. In addition, RAW-GFPERRaDAF2-derived OCs failed to transmigrate through osteoblast cell layers. Our data show that the impairment of ERRa function does not alter OC precursor proliferation and differentiation but does alter the adhesion/spreading and migration capacities of mature OCs.
Introduction
Osteoclasts (OCs) are large multinucleated cells of hematopoietic origin formed by the differentiation and fusion of mononuclear monocyte-macrophage lineage precursors after stimulation by receptor activator of nuclear factor kB-ligands (RANKL) and macrophage colony-stimulating factors (M-CSF; Boyle et al. 2003) . OC formation is associated with the expression of markers such as tartrate-resistant acid phosphatase (TRAP) and calcitonin receptor (CTR). Moreover, OCs are highly polarized cells, and several studies have identified a series of factors involved in OC spreading, polarity, adhesion, and migration, such as osteopontin (OPN), integrin subunits av, b1, b3, b5, cluster of differentiation 44 (CD44), c-src, and tumor necrosis factor receptor-associated factor 6 (Traf6; Denhardt & Noda 1998 , Chellaiah & Hruska 2003 , Chabadel et al. 2007 , Teitelbaum 2007 . OCs are highly migratory on bone surfaces or through collagen (Domon et al. 2002 , Delaisse et al. 2003 , Saltel et al. 2004 . Recently, we have found that OCs are also able to transmigrate through cell layers, a process that involves c-src and metalloproteinases (MMPs; Saltel et al. 2006) . Moreover, OCs exhibit several features, such as podosomes, that are associated with cell adhesion, migration, and invasion. In fact, we have previously shown that mature OCs, when spread on glass or plastic, form highly dynamic podosome belts (Destaing et al. 2003 at their periphery; whereas, when cultured on apatite mineral (corresponding to the mineral phase of bone), they exhibit another actin-rich structure, the sealing zone, which seals off the resorption area (Vaananen et al. 2000 , Saltel et al. 2004 .
Nuclear steroid receptors are transcription factors involved in various physiological regulatory processes, including multiple processes in bone (Gennari et al. 2007) . The superfamily to which nuclear receptors belong comprises both ligand-dependent molecules such as ERs and a large number of so-called orphan receptors, for which no ligands have yet been determined (Benoit et al. 2006) . Three orphan receptors, ER-related receptor a (ERRa), ERRb, and ERRg (NR3B1, NR3B2, and NR3B3 respectively, according to the Nuclear Receptors Nomenclature Committee 1999), share similarities with ERa and ERb (NR3A1 and NR3A2 respectively; Green et al. 1986 , Kuiper et al. 1996 , but they do not bind estrogen (Greschik et al. 2002 , Kallen et al. 2004 . Sequence alignment of ERRa and the ERs reveals a high similarity (68%) in the 66 amino acids (aa) of the DNA-binding domain, but only a moderate similarity (36%) in the ligand-binding domain, which may explain the fact that ERRa recognizes the same DNA-binding elements as ERs but does not bind estrogen (Giguere et al. 1988) . Several studies have shown that ERRa may activate gene transcription constitutively essentially through its coactivator-binding domain AF-2 (Vanacker et al. 1999 , Kallen et al. 2004 . ERRa regulates fatty acid oxidation and the adaptative bioenergetic response (Luo et al. 2003 , Huss et al. 2007 . ERRa is highly expressed in skeletal (bone and cartilage) tissues (Bonnelye et al. 2001 (Bonnelye et al. , 2007 and has been reported to regulate osteoblast development and bone formation in vitro (Bonnelye et al. 2001 (Bonnelye et al. , 2007 and in vivo (Delhon et al. 2009 , Teyssier et al. 2009 ). One study out of two has also described an ESRRA gene regulatory variant that is associated with bone mineral density and index in premenopausal women (Laflamme et al. 2005 , Giroux et al. 2008 .
In addition to its expression in osteoblasts, we have previously described ERRa expression in multinucleated TRAP-positive OCs in rat femurs after ovariectomy (Bonnelye et al. 2002) . We therefore decided to address the possible function of ERRa in osteoclastogenesis, including OC differentiation and adhesion-transmigration activities, using RAW264.7 cells transfected with an siRNA directed against ERRa or with a wild-type (WT) or a dominant-negative form of ERRa.
Materials and methods

Reagents
A pEGFP vector (Clontech) was used to obtain the stable RAW-GFP(Ct) and RAW-GFP-ERRaDAF2 (clones 1, 2, and 3) cell lines. Mouse ERRa cDNA (WT and DAF2) was obtained from mRNA extracted from primary OCs derived from spleen cells on day 6, using reverse transcription (RT)-PCR with specific primers ((NM_007953.1): ERRa upstream (177 bp): TCC AGC ACC ATG TCC AGC; ERRa downstream (WT) (1-1436 bp): CCA CCC CTT GCC TCA GTC CAT; ERRa downstream (DAF2): TCA TGC TGT CTG GCG GA (1-1341 bp); helix 11-12 deletion (42 aa); Bonnelye et al. 2007) . Amplicons were sequenced for verification. Anti-phospho-src (pTyr418) was from Abcam (ab4816); anti-integrin b3 chain was from BD (San Jose, CA, USA); anti-GFP was from Roche (monoclonal antibody mixture, clones 7.1 and 13.1). CY5-conjugated secondary antibodies (anti-rabbit, -mouse, -goat, and -hamster; 1/3000 final dilution) were from Jackson ImmunoResearch Laboratories (West Grove, PA, USA). The F-actin distribution was revealed with Alexa Fluor-546-Phalloidin from Molecular Probes (Eugene, OR, USA).
Cell culture
MC3T3-E1 cells were cultured in a-MEM containing 10% fetal bovine serum (FBS; Zirngibl et al. 2008) . On the day of transfection, cells were transfected using Lipofectamine 2000 (Invitrogen). Spleen cells from 6-week-old OF1 male mice, none modified RAW264.7 and RAW264.7 (GFP(Ct) and GFP-DAF2) cells were cultured for 8 and 6 days respectively in differentiation medium: a-MEM containing 10% FCS (BioWest, Nuaille, France), 20 ng/ml M-CSF and 20 ng/ml soluble recombinant RANKL (Destaing et al. 2003) .
RNA interference (siRNA)
The ERRa siRNA sequence was GCU AGU GCU CAG CUC UCU ACC CAA (403-426 bp) (Invitrogen). This sequence was rigorously analyzed by BLAST search, and no homologies were found; this included no homology with any of the ERa, ERb, ERRb, or ERRg, or with any other currently known nuclear receptors. The recommended negative control (Sc) by the manufacturer was used (Medium GC stealth RNA interference negative control duplexes; Invitrogen). ERRa siRNA and Sc were transfected twice into RAW cells following the manufacturer's protocol on days 3 and 4 after the addition of RANKL. mRNA was extracted on day 5.
Transactivation assay
HeLa cells were plated at 40 000 cells/well on a 24-well plate in DMEM (Sigma D5796) plus 10% FBS the day before transfection and incubated in a humidified incubator at 37 8C in a 95% air-5% CO 2 atmosphere. Media were changed just prior to transfection and again 24 h after transfection. Cells were transfected with Lipofectamine 2000 (Invitrogen) following the manufacturer's protocol using 100 ng expression vector, 200 ng luciferase reporter vector, and 10 ng pRL tk luc (Promega) for normalization. The pGL3 BSP reporter contains the rat bone sialoprotein promoter from K448 to K1 relative to the transcription start site cloned into pGL3B (Promega). Luciferase activities were measured 48 h later on an EG&G Berthold Microplate Luminometer LB96V (EG&G Berthold GmbH & Co., Oak Ridge, TN, USA) using the DualLuciferase reporter assay system (Promega). Transfections were repeated at least three times, and a representative experiment is shown.
Osteoclast differentiation and spreading test
After 6 days, GFP(Ct) and GFP-DAF2 (1, 2, and 3) cells were fixed with paraformaldehyde (PFA; Merck), then stained for TRAP using a histochemical kit (no. 387; Sigma-Aldrich), following the manufacturer's instructions. Multinucleated TRAP-positive cells containing three or more nuclei were counted as OCs. To quantify OCs spreading, OCs derived from GFP(Ct) and GFP-DAF2 (1, 2, and 3) cells were fixed and labeled with Alexa Fluor-546-Phalloidin to visualize, by fluorescence, specific F-actin structure-containing podosome belts that characterize spread OCs. Spread OCs were quantified by counting the podosome belts versus the total number of OCs, under a X40 (NA 1.0) Zeiss PlanAchromat objective and expressed as percentage. Results were plotted as the mean percentage of podosome belt number GS.D. of triplicate wells for GFP(Ct)-and GFP-DAF2 (1, 2, and 3)-derived OCs and for siRNA-transfected cells and are representative of two independent experiments each.
Adhesion test
OCs were detached and re-seeded on plastic in 12-well plates. The OCs were incubated at 37 8C in PBS containing 0 . 25 mM EDTA (PBS-EDTA) 4 h later.
The incubation was stopped either immediately (TZ0) or after 35 min (TZ35). Cultures were then fixed with PFA and stained for TRAP. Adhesion was quantified by counting OCs that were still adherent at TZ35 min versus the total number of OCs at TZ0 and expressed as percentage. Results were plotted as the mean percentage of adherent OCsGS.D. of triplicate wells for GFP(Ct)-and GFP-DAF2 (1, 2, and 3)-derived OCs and are representative of two independent experiments.
Transmigration assay
A transmigrating OC is an OC that had been detached and re-seeded on cell multilayers (for instance, osteoblasts) and that in 12 h is able to cross the osteoblast multilayers without destroying them and to spread on the plastic substratum beneath the osteoblast. We used the osteoblastic cell line MC3T3-E1, which we cultured for at least 1 week to obtain multilayers of osteoblasts. At the end of the OC differentiation process, OCs derived from GFP(Ct) and GFP-DAF2 (1, 2, and 3) were removed and re-seeded on the top of the multilayers of MC3T3-E1 cells as described previously . Primary OCs were also treated with echistatin at 10 K8 M (Sigma-Aldrich) for 24 h, then seeded on MC3T3 in the presence of echistatin at 10 K8 M for 12 h. Cells were then fixed after 20 min or 12 h, then permeabilized with 0 . 2% Triton X-100 for 7 min, and stained with Alexa Fluor-546-Phalloidin. OC transmigration efficiency was quantified using a X40 (NA 1.0) Zeiss Plan-Achromat objective by counting the transmigrated OCs versus the total number of OCs and expressed as percentage. Results were plotted as the mean of the number of the transmigrated OCsGS.D. of three wells for GFP(Ct)-and GFP-DAF2 (1, 2, and 3)-derived OCs and as the mean number of the transmigrated OCsG S.D. of three wells for non-treated OCs and OCs treated with echistatin. They are representative of three and two independent experiments respectively.
RT-PCR
Total RNA was extracted with TRIzol reagent from OC derived from spleen cells and RAW cells (GFP(Ct) and GFP-DAF2 (1, 2, and 3)) and from siRNA-transfected RAW cells. Samples of total RNA were reversetranscribed using SuperScript II retrotranscription kit (Invitrogen; Bonnelye et al. 2001) . Semi-quantitative PCR was performed for all studied genes. Real-time PCR was carried out to confirm regulated genes found by semi-quantitative PCR. Real-time RT-PCR was carried out by using the LightCycler system (SYBR Green; Qiagen) according to the manufacturer's instructions. PCRs were performed with the primers listed in Table 1 , and amplimers were all normalized to corresponding L32 values. Data normalization: in real-time PCR, each replicate average gene's C T was normalized to the average C T of L32 by subtracting the average C T of L32 from each replicate to give the DC T . Results are expressed as Log K2DDC T with DDC T equivalent to the DC T of the genes in GFP-DAF2 (1, 2, and 3) or siRNA subtracting to the DC T of the endogenous control (GFP(Ct), Scramble respectively).
Western blotting
Total proteins were extracted (pools from three 35 mm dishes for each condition) from RAW cells transfected with GFP(Ct) or GFP-ERRa (ERRaWT or ERRaDAF2) constructs according to the standard methods (Ausubel et al. 1996) . Western blot analyses were performed using a semidry system. Immunoblotting was performed with anti-GFP (Roche; monoclonal antibody mixture, clones 7.1 and 13.1). Blots were incubated overnight at room temperature with the polyclonal antibody diluted at 1/100, and binding was detected using HRPconjugated rabbit anti-mice antibodies (1/3000; Bio-Rad Laboratories) and chemiluminescence.
Immunofluorescence Cells were fixed in 4% paraformaldehyde, pH 7 . 2 for 10 min, permeabilized with 0 . 2% Triton X-100 for 7 min, then incubated with antibodies and AlexaFluor-546-Phalloidin as indicated. Cells were imaged with a confocal Zeiss LSM 510, using a X63 (NA 1.4) Plan Neofluor objective. To prevent contamination between fluorochromes, each channel was imaged sequentially, using the multitrack recording module, before merging. Z-cut pictures were obtained using Zeiss LSM 510 software.
Statistical analysis
Results for the real-time PCR analysis, the quantification of multinucleated TRAP-positive OCs, podosome belt numbers, adhesion, and transmigration were expressed as meanGS.D., and analyzed statistically by one-way ANOVA with the treatment group as variance and by Student's t-test with InStat software (version 2.01, GraphPad Software, San Diego, CA, USA).
Statistical significance was taken as P!0 . 05 (Student's t-tests *P!0 . 05, **P!0 . 01, ***P!0 . 001).
Results
ERRa mRNA expression increased during osteoclast differentiation in vitro Consistent with our previous findings on the presence of ERRa protein in multinucleated TRAP-positive cells in rat femur in vivo (Bonnelye et al. 2002) , we found, by real-time PCR, ERRa mRNA expressed throughout all the stages of OC differentiation: in primary leukocytes extracted from spleen (day 0), proliferation (day 2), mononucleated progenitor fusion (day 4), and maturation (days 6-8) with significant increases on days 4-8, when multinucleated OCs were starting to form until they reached maturity ( Fig. 1A and B ). For comparison, mRNA levels for ERRb, ERRg, and the late OC differentiation marker CTR were also assessed ( Fig. 1A and B). Interestingly and in contrast to ERRa, ERRg mRNA expression decreased dramatically during OC differentiation, while ERRb was not detected. As previously shown (Bonnelye et al. 2002) , ERRa is also expressed during OC differentiation of the RAW264.7 macrophage cell line, although fold changes in the expression level are less than that observed in primary OC cultures, which is probably due to the fact that RAW264.7 cells are already committed into the macrophage lineage (Fig. 1C) . Given its expression in mature OCs, we then checked whether ERRa was involved in their function.
Down-regulation of ERRa inhibits OPN and integrin b3 expression in RAW264.7-derived osteoclasts
To check the involvement of ERRa in OC function, we used a truncated version of ERRa lacking the coactivator-binding domain AF2, ERRaDAF2, which acts as a dominant-negative form of the receptor (Vanacker et al. 1999 , Bonnelye et al. 2007 ). We first confirmed that GFP-ERRaDAF2 acts dominant-negatively on the expression of OPN, an ERRa target gene in osteoblasts (Vanacker et al. 1998 , Zirngibl et al. 2008 , Teyssier et al. 2009 ), in the MC3T3-E1 cell model ( Fig. 2A) . GFP-ERRaWT was also made and transiently transfected with GFPERRaDAF2 into the RAW264.7 macrophage cell line. Protein size was evaluated by western blotting with a GFP antibody, which detected a protein of w80 kDa resulting from the fusion of the GFP (30 kDa) with the ERRaWT protein (around 53 kDa) used as a size control (Fig. 2B) . As expected, a band of slightly lower molecular weight was detected in GFP-ERRa DAF2 cells, corresponding to the truncation of the AF2 domain (42 aa; Fig. 2B ). Finally, we confirmed the efficacy of GFP-ERRaWT and GFP-ERRaDAF2 constructs by luciferase reporter assay with a (K448 to K1 bp) BSP promoter fragment (pGL3BSPLuc), an ERRa target gene in osteoblasts (Bonnelye et al. 2001) , in HeLa cells (Fig. 2C ). RAW264.7 cells were then stably transfected with the GFP vector alone, which served as control (Ct), and the dominant-negative GFP-ERRa DAF2 constructs. Three independent RAW-GFP-ERRa DAF2 (1, 2, and 3) and one GFP alone clone were obtained, namely GFP-DAF2 (1, 2, and 3) and GFP(Ct) respectively. GFP expression was tested with specific GFP primers after 3 days of culture at the end of the proliferation stage ( Fig. 2D and Table 1 ). GFP mRNA expression was observed in GFP(Ct) and all the three stable clones GFP-DAF2 (1, 2, and 3), with lower GFP expression in GFP-DAF2 (1, 2, and 3) versus GFP (Ct) cells (Fig. 2D ). As expected, a band of 1 . 7 kb was amplified with GFP (5 0 ) and ERRa (3 0 ) primers in the RNA isolated from GFP-DAF2 (1, 2, and 3) cells, whereas no band was detected in GFP(Ct) cells (Fig. 2D) . GFP-ERRaDAF2 expression was estimated to be tenfold less than the expression of the endogenous ERRa. Moreover, by using a GFP antibody, ERRa was localized by immunofluorescence in mature OCs derived from GFP(Ct) and GFP-DAF2 (1, 2, and 3) cells ( Fig. 4C and G) . As expected, ERRaDAF2 was detected in both the nucleus and the cytoplasm of GFP-DAF2-2-derived OCs ( Fig. 4G ; similar results were obtained for GFP-DAF2-1 and -3), whereas no GFP was detected in the nucleus of GFP(Ct)-derived OCs (Fig. 4C) . Also as expected, the expression level of the ERRa target genes, cytochrome c-1 (cytc; Huss et al. 2007) and OPN, was significantly reduced in all the three GFP-DAF2 clones in comparison with GFP(Ct) cells (Fig. 2E-G) , confirming the dominant-negative function of the truncated ERRaDAF2 construct. Interestingly, the expression of ERRg, which was expressed at only undetectable to very low levels in RAW264.7 cells, was markedly increased in two of three GFP-DAF2 clones in comparison with GFP(Ct) cells (Fig. 2G) .
To determine whether ERRa is involved in OC formation, GFP-DAF2 (1, 2, and 3) and GFP(Ct) cells were differentiated into mature multinucleated OCs in the presence of M-CSF and RANKL. Based on the cell counts after 3 days of culture, at the end of the proliferation stage, reduction of ERRa transactivation capacity had no effect on cell proliferation (data not shown). Concomitantly, the expression of early markers of OC differentiation, such as TRAP, c-fms, and RANKL (data not shown), and of the proliferation marker cyclin D1 was not affected (Fig. 2E and F) . Later during differentiation, while the OPN expression was still down-regulated, we found that integrin b3 chain expression was also decreased in GFP-DAF2 (1, 2, and 3) pEGFP empty plasmid (GFP(Ct)) and three clones stably transfected with pEGFP-ERRa-DAF2 (GFP-DAF2) were isolated. GFP expression was assessed, after 3 days of culture, by real-time PCR on triplicate samples and normalized against that of the ribosomal protein gene L32. (ANOVA, PZ0 . 0001 for GFP in GFP-DAF2 (1, 2, and 3) versus GFP(Ct)). (E and F) As expected, OPN expression was decreased (ANOVA, PZ0 . 0003 for OPN in GFP-DAF2 (1, 2, and 3) versus GFP(Ct)). mRNA expression of the early markers of OC differentiation (c-fms, TRAP) and proliferation (cyclin D1) was not different in GFP-DAF2 (1, 2, and 3) cells compared with that in GFP(Ct) cells. (G) cytc was downregulated in GFP-DAF2 (1, 2, and 3) versus GFP(Ct) (ANOVA, PZ0 . 0096). On the other hand, ERRg was expressed in two of the GFP-DAF2 clones (2, 3) versus GFP(Ct) (ANOVA, P!0 . 0001 for ERRg). E BONNELYE, F SALTEL, A CHABADEL and others . ERRa and osteoclasts compared with GFP(Ct) cells (Fig. 3A) . On the other hand, the expression of av, b1 and b5 integrin chain subunits, c-src, CD44, and Traf6 was not affected (Fig. 3A , and data not shown). Moreover, no differences were observed in the expression of OC factors involved in OC fusion (dendritic cell-specific transmembrane protein DC-STAMP (DCS)) or apoptosis (Bcl2 and Bax) in GFP-DAF2 (1, 2, and 3)-versus GFP(Ct)-derived OCs (Fig. 3A) .
To confirm the putative functional role of ERRa in OC as suggested by the results with the dominantnegative form of ERRaDAF2, we then checked whether the expression of OPN and integrin b3 chain would be similarly altered by the overexpression of ERRaWT or by an siRNA directed against ERRa. Transient transfection of ERRaWT in RAW264.7 cells at day 3 (transfection efficiency was very low at earlier stages) up-regulated the expression of OPN and integrin b3 chain at 48 h (Fig. 3B) . On the other hand, ERRa siRNA elicited a 60% decrease in the ERRa expression level at day 5 (Fig. 3C) . OPN as well as integrin b3 expression was also down-regulated in OCs derived from ERRa siRNA-transfected RAW cells compared with control-transfected cells (Sc). Moreover, ERRg expression was higher in ERRa siRNA-treated cells (Fig. 3C) , consistent with the results in GFP-DAF2 (1, 2, and 3)-derived OCs (cf. Fig. 2 ). Taken together, these data suggest that ERRa does not play a role in the ERRα-∆AF2
A Figure 3 Implication of ERRa in integrin b3 expression in GFP-DAF2-derived OCs (A) Total RNA was extracted from GFP(Ct)-and GFP-DAF2 (1, 2, and 3)-derived OCs after 6 days of culture, and real-time PCR was performed on triplicate samples by using primers specific for several genes involved in OCs spreading. Quantification shows a statistically significant decrease in b3 integrin and OPN in GFP-DAF2 (1, 2, and 3) (ANOVA, PZ0 . 0002; ANOVA, PZ0 . 0001, DAF2 (1, 2, and 3) versus C t for OPN and b3 respectively). Markers for adhesion (integrin subunits av, b1, and b5), OC cell-cell fusion (DC-STAMP) were not modified. To unravel the function of ERRa in OCs, GFP-DAF2 (1, 2, and 3) and GFP(Ct) RAW cells were differentiated into mature multinucleated OCs in the presence of M-CSF and RANKL. After 6 days, no difference was observed between the number of large multinucleated TRAP-positive OCs and between the nuclei number in GFP-DAF2 (1, 2, and 3) versus GFP(Ct) cells, suggesting that ERRa does not affect OC differentiation from macrophages ( Fig. 4I-J) . However, TRAP-positive GFP-DAF2-2-derived OCs (Fig. 4E ) appeared less spread than TRAP-positive GFP(Ct)-derived OCs (Fig. 4A ). This morphological difference was well correlated to their actin cytoskeletal organization. Indeed, well spread GFP(Ct)-derived OCs exhibited a typical podosome belt (Fig. 4B, D and K) , whereas in less spread Figure 4 Involvement of ERRa in OC spreading. RAW-GFP(Ct) and RAW-GFP-DAF2 (1, 2, and 3) cells were differentiated for 6 days in culture in the presence of RANKL. (A and E) After TRAP staining, the total number of OCs (I) were quantified. (J) After TRAP staining, the number of nuclei per hundred OCs for each clone was quantified. Podosome belt formation was evaluated after actin staining of (K) GFP(Ct)-and GFP-DAF2 (1, 2, and 3)-derived OCs (ANOVA, PZ0 . 0001), or (L) ERRa siRNA or Sc-transfected RAW cell-derived OCs versus non-transfected cells (C t ) (ANOVA; PZ0 . 0019). (C and G) Immunolabeling for GFP shows nuclear and cytoplasm location for ERRa. Staining using rhodamine-phalloidin (B, D, F, and H) showed the actin cytoskeletal organization of GFP-DAF2 (1, 2, and 3) into actin-containing rings (F and H), while GFP(Ct)-derived OCs exhibited podosome belts (B and D). BarZ20 mm (A-H). Full color version of this figure available via http://dx.doi.org/10.1677/JME-10-0024.
GFP-DAF2 (1, 2, and 3)-derived OCs, podosomes were organized as clusters or small rings (Fig. 4F, H and K) . Similar results were obtained in RAW cells transfected with ERRa siRNA versus Sc siRNA or non-transfected cells (Fig. 4L) . Together with the down-regulation of both OPN and b3 integrin chain, these latter results strongly suggest that ERRa is involved in OC adhesion.
Disruption of OC adhesion and transmigration: implication of integrin b3 in GFP-DAF2-derived OC Down-regulation of b3 expression in GFP-DAF2-2-derived OCs at day 6 (Fig. 3A) was confirmed by immunofluorescence using an antibody against integrin b3 (Fig. 5A and D) . As expected, intense b3 integrin subunit staining was localized around the actin core of podosomes organized in a belt in GFP(Ct)-derived OCs at day 6 (Fig. 5A and B, see merged in Fig. 4C ). In contrast, labeling for b3 integrin subunit protein was diffusely distributed within GFP-DAF2-2-derived OCs at day 6 (Fig. 5D and E, see merged in F). Since we, and others, have shown the importance of c-src in integrin signaling for actin organization, we looked for phosphorylated c-src localization in OCs expressing the dominant-negative form of ERRa. Whereas phosphorylated c-src was distributed around the podosome belt in GFP(Ct)-derived OCs on day 6 (Fig. 5G and H, see merged in I), it was diffusely GFP-∆AF2-2 GFP-∆AF2-2 GFP(Ct) Figure 5 Integrin subunit b3 expression and localization are altered in GFP-DAF2-derived OCs. (A-L) b3 integrin subunit (A, D, C, and F in green), phosphorylated c-src (G, J, I, and L in green), and actin (B, C, E, F, H, I, K, and L in red) were immunostained in control (A-C; G-I) and in GFP-DAF2-2-derived OCs (D-F; J-L). Whereas control OC formed typical podosome belts with actin dots surrounded by b3 integrin and phosphorylated c-src (A-C; G-I), podosomes of GFP-DAF2-2-derived OCs were disorganized with mislocalized b3 integrin and phosphorylated c-src (D-F; J-L). Merged images of the closeup areas of actin, b3, and phosphorylated c-src respectively are also shown (C, F, I, and L). BarZ20 mm. (M) Adhesion ability was also evaluated (ANOVA, PZ0 . 0001; DAF2 (1, 2, and 3)), while (N) OC viability was evaluated by counting the total number of OCs used in the adhesion test at TZ0. localized in GFP-DAF2-2 cells (Fig. 5J and K, see merged in L). Similarly, vinculin localization was disrupted in GFP-DAF2 cells (data not shown) compared with GFP(Ct)-derived OCs at day 6. These results suggest that disturbing ERRa function impairs a signaling pathway linked to OPN, integrin b3, activated c-src, and actin organization. Moreover, and in agreement with the decrease in mature OC spreading, we observed a decrease in OC adhesion in GFP-DAF2 (1, 2, and 3)-derived OCs compared with GFP(Ct)-derived cells (by 40% in DAF2-1, 50% in DAF2-2, and 68% in DAF2-3 compared with GFP(Ct); Fig. 5M ). It was observed that the differences in OC viability, as reflected by OC number, cannot account for the differences in spreading between GFP(Ct)-and GFP-DAF2 (1, 2, and 3)-derived OCs (TZ0; Fig. 5N ).
To address further the consequences of disrupting the actin structure due to the expression of a dominantnegative form of ERRa in OCs, we then checked whether OC transmigration was affected . To this end, mature GFP-DAF2 (1, 2, and 3)-and GFP(Ct)-derived OCs were seeded onto confluent osteoblastic MC3T3-E1 cells. After 20 min, large rounded OCs (identified by GFP expression in green, white arrows) derived from GFP-DAF2 (1, 2, and 3) (Fig. 6G , see Z-cut section E) and GFP(Ct) (Fig. 6C , see Z-cut section A) cells were localized on the top of confluent osteoblastic MC3T3-E1 cell layers (red, see white asterisk). After 12 h, OCs derived from GFP(Ct) cells were well spread and attached to the substratum beneath the osteoblasts (Fig. 6D , and Z-cut section in B), showing that they had transmigrated through the MC3T3-E1 cell layers. In contrast, after 12 h of culture, OCs derived from GFP-DAF2-2 cells appeared 'frozen' on the top of the MC3T3-E1 cell layers where they maintained a rounded shape (Fig. 6H, (data not shown). Quantification of transmigrated OCs versus non-transmigrated OCs confirmed a significant decrease (72% in DAF2-1, 63% in DAF2-2, and 67% in DAF2-3) in the transmigrated OC numbers in GFP-DAF2 (1, 2, and 3)-compared with GFP(Ct)-derived OCs (Fig. 6I) . Viability of the transmigrated GFP(Ct)-and GFP-DAF2 (1, 2, and 3)-derived OCs is equivalent (total OC number at TZ12 h; Fig 6J) . Interestingly, the inhibition of transmigration observed with the knockdown of ERRa correlated with that observed after blocking integrins with echistatin, an RGD disintegrin, in primary OCs re-seeded onto confluent osteoblastic MC3T3-E1 cells (Fig. 6K ).
Discussion
We report that the overexpression or knockdown of ERRa function in the RAW264.7 macrophage cell line either by stable transfection of a dominant-negative form of ERRa, GFP-ERRaDAF2 or by ERRa siRNA leads to modulation of the expression of OPN and b3 integrin subunit with concomitant actin cytoskeletal disorganization in the podosome belt, reduced adhesion on tissue culture plastic or glass, and reduced transmigration activity. Although ERRa knockout mice and cells are now available, our work was initiated when these were not available, and both our stable and transient knockdown approaches gave comparable and highly reproducible results. It is therefore not clear why no detectable alteration in the OC parameters was observed in ERRa knockout mice (Delhon et al. 2009 , Teyssier et al. 2009 ), but it seems likely that compensatory mechanisms involving ERRg may be operating, since we found that ERRg is expressed in RAW264.7 cells when ERRa function is disrupted. The molecular basis for the ERRa effect on cell mobility is of interest because OPN, which is expressed in several motile cell types including OCs and many tumor cell lines (Standal et al. 2004) , has been described as a target gene of ERRa in promoter reporter assays in vitro (Vanacker et al. 1998 , Zirngibl et al. 2008 . OPN is involved in cell adhesion and migration and promotes cell attachment to bone (Denhardt & Noda 1998) . Adhesion receptors avb1, avb3, and avb5 integrins and the hyaluronan receptor (CD44) are all receptors for OPN, and their interactions are crucial for OC adhesion and motility (McHugh et al. 2000 , Chellaiah & Hruska 2003 . Notably, OPN is known to stimulate glass-adherent OC migration through the avb3 integrin-induced activation of c-src and actin cytoskeletal reorganization into podosome belts (Duong et al. 1998) . While av, b1, and b5 integrin subunits and CD44 were not affected by the changes in ERRa activity, the expression of the b3 integrin subunit was down-regulated in siRNA and GFP-DAF2-derived OCs. In addition, more detailed studies in GFP-DAF2-derived OCs showed that the disruption of podosome belt formation was accompanied by an aberrant/diffuse distribution of the b3 integrin subunit, activated c-src, and vinculin. Thus, it is likely that the inhibition of adhesion and disruption of the podosome belt observed in GFP-DAF2-derived OCs is a consequence of the reduced expression of both OPN and b3 that consequently induced the disrupted localization of activated c-src. Moreover, although neither of the latter is known to be involved in OC transmigration, the fact that avb3 is involved in monocyte transendothelial migration, that echistatin, an RGD disintegrin, induces a decrease in OC transmigration, and that c-src is involved in OC transmigration through MC3T3-E1 cell layers suggests that the b3 integrin subunit may be involved in OC transmigration (Weerasinghe et al. 1998 . Indeed, in the presence of PP2, a c-src inhibitor, OCs maintain a rounded shape and sit on the top of MC3T3-E1 cell layers ) in a manner similar to GFP-DAF2-derived OCs. These data suggest that the disruption of activated c-src localization may, at least in part, be due to down-regulated OPN and/or integrin subunit b3 expression and may be responsible for the inhibition of transmigration in GFP-DAF2-derived OCs.
We have previously shown that ERRa positively regulates osteoblast formation in rat calvarial cells in vitro, acting at multiple developmental times to regulate both proliferation and differentiation events (Bonnelye et al. 2001) . However, more recent data with ERRa knockout mice and with human bone marrow stromal cells suggest that ERRa may play a negative regulatory role in other models or at other developmental times (Delhon et al. 2009 , Teyssier et al. 2009 ). Further complicating the issue, one study suggests that an ESRRA gene regulatory variant leading to increased ERRa expression is associated with increased bone mineral density in premenopausal women (Laflamme et al. 2005) , although a recent report has failed to confirm the observation (Giroux et al. 2008) . Such apparently complex and multiphasic activities, complicated by potential compensatory mechanisms involving other ERR family members, are in keeping with our current data showing that down-regulation of ERRa decreases OC transmigration, suggesting that ERRa may positively regulate OC migration. Altogether, the data suggest that ERRa may contribute to bone homeostasis not only through effects on osteoblast lineage cells but also on OCs.
ERRa expression in other highly motile cells such as dendritic cells and macrophages (Sonoda et al. 2007 ) supports a role for ERRa in inflammatory diseases associated with osteoclastic bone degradation such as rheumatoid arthritis and other diseases, where avb3 and OPN are also implicated (Wilder 2002 , Yumoto et al. 2002 . In this regard, recently, and similarly to our data on OC migration, siRNA-mediated knockdown of ERRa in the highly aggressive breast carcinoma MDA-231 cell line resulted in a dramatic decrease in their migration (Stein et al. 2008) . We thus hypothesize that the ERRa-regulated OPN and integrin subunit b3 pathway that we described here may also be operative in cancer cells.
In conclusion, ERRa is expressed in OCs where it regulates the expression of OPN and integrin subunit b3, and plays a role in the spreading, organization, and/or stabilization of podosomes at the cell periphery, as well as in the adhesion and transmigration in a RAW cell culture model in vitro. Further understanding of the mechanisms by which ERRa modulates migration in the normal development and disease is required. In the meantime, our data suggest that the regulation of ERRa activity may provide a new therapeutic strategy for inflammatory and bone diseases associated with an imbalance in bone remodeling due to excessive OC resorption.
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